Hypermethylation resulting in epigenetic silencing was first demonstrated in the studies of retinoblastoma patients, in which hypermethylation was discovered in the promoter of the retinoblastoma tumor-suppressor (RB1) gene (Greger et al., 1989). Here, RB1 is linked to retinoblastoma.